| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 03/31/2011 | US20110076299 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
| 03/31/2011 | US20110076298 Soluble stabilized trimeric hiv env proteins and uses thereof |
| 03/31/2011 | US20110076292 Benzoxazepin pi3k inhibitor compounds and methods of use |
| 03/31/2011 | US20110076291 Benzoxepin pi3k inhibitor compounds and methods of use |
| 03/31/2011 | US20110076276 Novel HIV reverse transcriptase inhibitors |
| 03/31/2011 | US20110076268 Antibodies against human respiratory syncytial virus (RSV) and methods of use |
| 03/31/2011 | US20110076265 Monoclonal antibodies having homosubtype cross-neutralization properties against influenza a viruses subtype h1 |
| 03/31/2011 | US20110076264 Immunoglobulin cleavage fragments as disease indicators and compositions for detecting and binding such |
| 03/31/2011 | US20110076251 Novel therapeutic agents against hepatitis |
| 03/31/2011 | US20110076250 Biodegradable Absorbents and Methods of Preparation |
| 03/31/2011 | US20110076249 Immunotherapy for immune suppressed patients |
| 03/31/2011 | US20110076248 Immunizing compositions comprising hiv-1 proviral constructs with an inactive p6 gag tsg101 uev binding domain capable of producing budding-defective viral particles that remain tethered to the cell surface. |
| 03/31/2011 | US20110076244 Surface coatings for skin |
| 03/31/2011 | US20110076240 Antifungal and Anti-Cariogenic Cellobio-Oligosaccharides Produced by Dextransucrase |
| 03/31/2011 | US20110076233 Delivery System for Cytotoxic Drugs by Bispecific Antibody Pretargeting |
| 03/31/2011 | CA2801143A1 Disinfecting agent comprising eugenol, terpineol and thymol |
| 03/31/2011 | CA2775697A1 Cyclic peptide inhibitors of hepatitis c virus replication |
| 03/31/2011 | CA2775204A1 Fused imidazo [3, 2 - d] pyraz ines as pi3 kinase inhibitors |
| 03/31/2011 | CA2775027A1 Maleic acid salt and crystal thereof |
| 03/31/2011 | CA2774750A1 Treatment and prevention of hiv infection |
| 03/31/2011 | CA2774731A1 Dihydropteridinone derivatives, preparation process and pharmaceutical use thereof |
| 03/31/2011 | CA2774387A1 Novel macrocyclic inhibitors of hepatitis c virus replication |
| 03/31/2011 | CA2773306A1 Process |
| 03/31/2011 | CA2773305A1 Crystalline methylthioninium chloride hydrates |
| 03/31/2011 | CA2772962A1 Method of preparing plant-derived vlps |
| 03/31/2011 | CA2768523A1 Heterocyclic antiviral compounds |
| 03/30/2011 | EP2302059A1 Modifications of hiv Env, Gag, and Pol enhance immunogenicity for genetic immunization |
| 03/30/2011 | EP2301971A1 Antibodies that bind both BCMA and TACI |
| 03/30/2011 | EP2301970A1 Human antibodies that bind human IL-12 and methods for producing |
| 03/30/2011 | EP2301967A2 Single domain antibodies for nasal administration |
| 03/30/2011 | EP2301964A1 High affinity HIV T cell receptors |
| 03/30/2011 | EP2301955A2 Varicella Zoster virus vaccine |
| 03/30/2011 | EP2301945A1 Hydrates of erythromycin salts, the preparation and the use thereof |
| 03/30/2011 | EP2301916A2 4-aminotetracyclines and methods of use thereof |
| 03/30/2011 | EP2301915A1 7-(diethylamino)methyl substituted tetracycline having target therapeutic activities |
| 03/30/2011 | EP2301914A1 7,9-Substituted tetracycline compounds |
| 03/30/2011 | EP2301913A1 7,9-Substituted tetracycline compounds |
| 03/30/2011 | EP2301912A2 4-aminotetracyclines and methods of use thereof |
| 03/30/2011 | EP2301626A2 Antibiotic for use in local infection |
| 03/30/2011 | EP2301565A1 Use of proteasome inhibitors for the treatment of viral infections |
| 03/30/2011 | EP2301550A1 Tetracycline compounds having target therapeutic activities |
| 03/30/2011 | EP2301545A1 Thioxanthene derivatives for use in the treatment of infectious diseases |
| 03/30/2011 | EP2301544A1 Quinoline derivatives as intermediates to mycobacterial inhibitors |
| 03/30/2011 | EP2301541A1 Antibiotic compositions for treatment of the eye, ear and nose |
| 03/30/2011 | EP2301534A1 Amino-methyl substituted tetracycline compounds |
| 03/30/2011 | EP2301529A1 Hydroxymethylbutyrate compositions and uses thereof |
| 03/30/2011 | EP2301524A1 Inhalable aztreonam without arginine for treatment and prevention of pulmonary bacterial infections |
| 03/30/2011 | EP2301362A1 Mixture on the basis of a sourdough |
| 03/30/2011 | EP2300492A1 A novel antiviral peptide against avian influenza virus h9n2 |
| 03/30/2011 | EP2300491A1 Hepatitis c virus inhibitors |
| 03/30/2011 | EP2300490A1 Hepatitis c virus inhibitors |
| 03/30/2011 | EP2300477A1 Tricyclic nitrogen containing compounds and their use as antibacterials |
| 03/30/2011 | EP2300476A1 Tricyclic nitrogen containing compounds and their use as antibacterials |
| 03/30/2011 | EP2300463A1 Heterocyclic urea derivatives for the treatment of bacterial infections |
| 03/30/2011 | EP2300433A1 Hiv integrase inhibitors from pyridoxine |
| 03/30/2011 | EP2300005A1 Small molecule inhibitors of botulinum neurotoxins |
| 03/30/2011 | EP2299979A2 Controlled release antimicrobial compositions and methods for the treatment of otic disorders |
| 03/30/2011 | EP2125736B1 Substituted acetophenones useful as pde4 inhibitors |
| 03/30/2011 | EP2057125B1 Non-nucleoside reverse transcriptase inhibitors |
| 03/30/2011 | EP1877403B1 Mono-lysine salts of azole compounds |
| 03/30/2011 | EP1861424B1 Human monoclonal antibodies against hendra and nipah viruses |
| 03/30/2011 | EP1856066B1 Anti-cancer and anti-microbial oxazolidinones and analogues |
| 03/30/2011 | EP1802297B1 Compositions and methods for treatment of disease caused by yersinia spp infection |
| 03/30/2011 | EP1507515B1 Free-flowing, powdery composition containing alpha-liponic acid (-derivatives) |
| 03/30/2011 | EP1503773B1 Hepatoprotective activity of 2 -p-hydroxybenzoylmussaenosidic acid |
| 03/30/2011 | EP1500698B1 Cell with depression or deletion of the activity of protein participating in gdp-fucose transport |
| 03/30/2011 | EP1361890B1 Influenza vaccine formulations for intradermal delivery |
| 03/30/2011 | EP1305007B1 Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors |
| 03/30/2011 | CN1906208B Inhibitors of serine proteases, particularly HCV NS3-NS4A proteases |
| 03/30/2011 | CN1903035B Synergistic microbicidal combination |
| 03/30/2011 | CN1863813B Novel tricyclic nucleosides or nucleotides as therapeutic agents |
| 03/30/2011 | CN101998990A Improvements in preparation of influenza virus vaccine antigens |
| 03/30/2011 | CN101998954A Conformationally restricted biphenyl derivatives for use as hepatitis c virus inhibitors |
| 03/30/2011 | CN101998952A Hepatitis c virus inhibitors |
| 03/30/2011 | CN101998856A Zn/trimethoprim combination therapy |
| 03/30/2011 | CN101993869A Relevant experimental technique of epiphyte secondary metabolism function reformation and application thereof |
| 03/30/2011 | CN101993498A Adenovirus vector avian influenza recombinant vaccine |
| 03/30/2011 | CN101993492A ScFv antibody for resisting H5N1 type highly-pathogenic avian influenza and application thereof |
| 03/30/2011 | CN101993478A Multi-epitope recombinant protein of epstein-barr (EB) virus latent membrane protein 2 and application thereof |
| 03/30/2011 | CN101993448A Anti-mycobacteria oxazolidinones used for treating infectious disease |
| 03/30/2011 | CN101993446A Novel benzanthracene cyclic compounds and preparation method and use thereof |
| 03/30/2011 | CN101993439A Lamivudine crystal form and preparation method thereof |
| 03/30/2011 | CN101993436A Method for preparing imidazole antifungal medicine derivate |
| 03/30/2011 | CN101993424A Lariciresinol and derivative, preparation method and application thereof |
| 03/30/2011 | CN101993399A Method for preparing florfenicol sodium succinate by one-pot method |
| 03/30/2011 | CN101991869A Chinese medicament capable of safely transforming human immunodeficiency virus (HIV) antibodies of acquired immune deficiency syndrome (AIDS) patient to be negative by utilizing uranium fission effect |
| 03/30/2011 | CN101991868A Sterilizing, disinfecting and skin-moisturizing medical ultrasonic coupling agent and preparation method thereof |
| 03/30/2011 | CN101991864A Leptospira interrogans DNA (Deoxyribose Nucleic Acid) vaccine as well as construction method and application thereof |
| 03/30/2011 | CN101991863A Double-target DNA vaccine and constructing method thereof |
| 03/30/2011 | CN101991855A Menstruum special for cefpirome sulfate |
| 03/30/2011 | CN101991849A Preparation method of swine pseudorabies vaccine |
| 03/30/2011 | CN101991848A Synthetic peptide vaccine for swine fever and application thereof |
| 03/30/2011 | CN101991847A Triple inactivated vaccine against dairy cattle mastitis and preparation method thereof |
| 03/30/2011 | CN101991845A Duck infectious serositis inactivated vaccine emulsification method |
| 03/30/2011 | CN101991844A Edwardsiella tarda recombinant subunit vaccine and application thereof |
| 03/30/2011 | CN101991810A Medicament for treating hepatitis A and hepatitis B |
| 03/30/2011 | CN101991789A Preparation with functions of clearing away heat and toxic material and diminishing swelling and preparation method thereof |
| 03/30/2011 | CN101991788A Preparation with effects of clearing heat and detoxicating, and diminishing swelling and relieving pain and preparation method thereof |
| 03/30/2011 | CN101991781A Traditional Chinese medicine preparation for treating tetanus |
| 03/30/2011 | CN101991776A Chinese traditional medicine preparation for treating viral influenza |